entertainment -WSS

entertainment

author：comprehensive 2025-09-28 04:59:01 - browse：75595

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Venture capitalist Bob Kocher on the state of digital health

Wikipedia

explore

WSS

Military medical care influenced by rank and race, new study finds

Steward Health Care expansion into Malta flopped

NVIDIA and Google execs on the future of AI and drug discovery

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Arc Institute generative AI designs new CRISPR systems

Cancer, immunology, HIV research ensnared in fetal tissue politics

hotspot

entertainment

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast, live from the STAT Breakthrough Summit East

DIEP, the 'gold standard' of breast reconstruction, is under threat

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Apple is now the first public company to be valued at $3 trillion

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Bright Health sells Medicare Advantage business to Molina

Medical devices makers are asking for forgiveness, not permission

State Dept. review finds Biden bears some blame for Afghanistan failures

Addiction experts warn against a second 'war on drugs'

Wikipedia

Cytokinetics CEO stresses company can launch heart drug on its own

Readout LOUD podcast: Live from STAT Breakthrough Summit West

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

'Patient friction coefficient' can gauge a clinical trial's patient burden

Addiction experts warn against a second 'war on drugs'

With Wegovy coverage, Medicare patients may face high costs

focus

Wikipedia

explore

explore